These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20151158)

  • 21. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
    Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
    Aicardi G; Benso L; Vignolo M; Terragna A; Verrina E; Cordone G; Coppo R; Sernia O; Sardella ML; Di Battista E
    Br J Rheumatol; 1993 May; 32 Suppl 2():39-43. PubMed ID: 8495279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term consequences of different immunosuppressive regimens for renal allografts.
    Isoniemi HM; Ahonen J; Tikkanen MJ; von Willebrand EO; Krogerus L; Eklund BH; Höckerstedt KV; Salmela KE; Häyry PJ
    Transplantation; 1993 Mar; 55(3):494-9. PubMed ID: 8456467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of deflazacort on bone mineral density in renal transplant recipients.
    Kim MS; Kim YS; Lim SK; Kim SI; Moon JI; Park K
    Transplant Proc; 1998 Nov; 30(7):3041-2. PubMed ID: 9838340
    [No Abstract]   [Full Text] [Related]  

  • 25. Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects.
    Elli A; Rivolta R; Palazzi P; Mascaretti L; Puglisi G; Parenti M; Sioli V; Di Palo FQ
    Transplant Proc; 1990 Aug; 22(4):1689-90. PubMed ID: 2202126
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of renal allograft acute rejection with methylprednisolone: effect of fixed dose versus dose per body mass index.
    Douzdjian V; Rice JC; Gugliuzza KK; Fisch JC; Carson RW
    Clin Transplant; 1996 Jun; 10(3):310-5. PubMed ID: 8826672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density after renal transplantation in children.
    Feber J; Cochat P; Braillon P; Castelo F; Martin X; Glastre C; Chapuis F; David L; Meunier PJ
    J Pediatr; 1994 Dec; 125(6 Pt 1):870-5. PubMed ID: 7996358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
    Aicardi G; Milani S; Imbimbo B; Vignolo M; Di Battista E; Gusmano R; Terragna A; Cordone G; Cottafava F; Coppo R
    Calcif Tissue Int; 1991 Apr; 48(4):283-7. PubMed ID: 2059880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study.
    ter Meulen CG; van Riemsdijk I; Hené RJ; Christiaans MH; Borm GF; Corstens FH; van Gelder T; Hilbrands LB; Weimar W; Hoitsma AJ
    Transplantation; 2004 Jul; 78(1):101-6. PubMed ID: 15257046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
    Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
    Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Oh HK; Dienst S
    Transplantation; 1988 Jan; 45(1):53-5. PubMed ID: 3276062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
    Isoniemi H; Tikkanen MJ; Ahonen J; Häyry P
    Transpl Int; 1991 Sep; 4(3):130-5. PubMed ID: 1958276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in body composition as determinants of longitudinal changes in bone mineral measures in 8 to 26-year-old female twins.
    Young D; Hopper JL; Macinnis RJ; Nowson CA; Hoang NH; Wark JD
    Osteoporos Int; 2001; 12(6):506-15. PubMed ID: 11446568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal adult height after steroid-withdrawal within 6 months of pediatric kidney transplantation: a 20 years single center experience.
    Klare B; Montoya CR; Fischer DC; Stangl MJ; Haffner D
    Transpl Int; 2012 Mar; 25(3):276-82. PubMed ID: 22187956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early steroid withdrawal in pediatric renal transplantation].
    Delucchi B A; Valenzuela A M; Ferrario B M; Lillo D AM; Guerrero G JL; Rodríguez S E; Cano Sch F; Cavada Ch G; Godoy L J; Rodríguez H J; González G G; Buckel B E; Contreras M L
    Rev Med Chil; 2006 Nov; 134(11):1393-401. PubMed ID: 17277852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of growth in low-body-weight kidney transplant Egyptian children: 25-year experience.
    Mosaad AM; Hamdy AF; Hassan NM; Donia AF; Gheith O; Salem Mel-S; El-Shahawy el-ML; Bakr MA; Ghoneim MA
    J Nephrol; 2012; 25(3):363-72. PubMed ID: 22081295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased bone mineral density in the pediatric renal transplant population.
    Acott PD; Crocker JF; Wong JA
    Pediatr Transplant; 2003 Oct; 7(5):358-63. PubMed ID: 14738295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia.
    Grote FK; Van Suijlekom-Smit LW; Mul D; Hop WC; Ten Cate R; Oostdijk W; Van Luijk W; Jansen-van Wijngaarden CJ; De Muinck Keizer-Schrama SM
    Arch Dis Child; 2006 Jan; 91(1):56-60. PubMed ID: 16223747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.